Literature DB >> 19467449

Sarcomere mutations in cardiogenesis and ventricular noncompaction.

Elizabeth McNally1, Lisa Dellefave.   

Abstract

Ventricular noncompaction is a form of cardiomyopathy where increased trabeculation is present frequently affecting the left ventricle and resembling an embryonic state of heart development. Clinically, left ventricular noncompaction may manifest as congestive heart failure, arrhythmias, and/or thromboembolic events. There are multiple genes linked to noncompaction, but recently, sarcomere gene mutations were found in both familial and sporadic cases of noncompaction. The association of noncompaction with sarcomere mutations supports the classification of ventricular noncompaction as cardiomyopathy and raises interesting questions regarding the continuum of hypertrophic cardiomyopathy, dilated cardiomyopathy, and noncompaction. The mutational spectrum of sarcomere genes in these disorders highlights the importance of the MYH7 gene encoding beta-myosin heavy chain and ACTC1 encoding the cardiac actin gene. Intriguingly, these mutations also share a low but definitive incidence of congenital heart malformations including septal defects. These human genetic findings support that normal myocardial and sarcomere function are required for proper compaction and septation and that these mutations also portend a high risk of developing heart failure in later life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467449     DOI: 10.1016/j.tcm.2009.03.003

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  15 in total

1.  Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes.

Authors:  Shale Dames; Jacob Durtschi; Katherine Geiersbach; Jack Stephens; Karl V Voelkerding
Journal:  J Biomol Tech       Date:  2010-07

Review 2.  Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor.

Authors:  Jeffrey R Moore; Leslie Leinwand; David M Warshaw
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

3.  Inhibition of Diaphanous Formin Signaling In Vivo Impairs Cardiovascular Development and Alters Smooth Muscle Cell Phenotype.

Authors:  Laura Weise-Cross; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-17       Impact factor: 8.311

4.  Sudden infant death syndrome and left ventricular hypertrabeculation-hidden arrhythmogenic entity?

Authors:  J Ker; L Du Toit-Prinsloo; W F P van Heerden; G Saayman
Journal:  Clin Med Insights Cardiol       Date:  2010-09-17

Review 5.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

6.  Subendocardial fibrosis in left ventricular hypertrabeculation-cause or consequence?

Authors:  J Ker; L Du Toit-Prinsloo; W F P Van Heerden; G Saayman
Journal:  Clin Med Insights Cardiol       Date:  2011-02-02

Review 7.  Genetic advances in sarcomeric cardiomyopathies: state of the art.

Authors:  Carolyn Y Ho; Philippe Charron; Pascale Richard; Francesca Girolami; Karin Y Van Spaendonck-Zwarts; Yigal Pinto
Journal:  Cardiovasc Res       Date:  2015-01-29       Impact factor: 10.787

8.  Transcriptome responses to heat stress in hypothalamus of a meat-type chicken.

Authors:  Hongyan Sun; Runshen Jiang; Shengyou Xu; Zebin Zhang; Guiyun Xu; Jiangxia Zheng; Lujiang Qu
Journal:  J Anim Sci Biotechnol       Date:  2015-02-17

Review 9.  Molecular genetics of congenital atrial septal defects.

Authors:  Maximilian G Posch; Andreas Perrot; Felix Berger; Cemil Ozcelik
Journal:  Clin Res Cardiol       Date:  2009-12-11       Impact factor: 5.460

10.  Myocardin-related transcription factors are required for cardiac development and function.

Authors:  Mayssa H Mokalled; Kelli J Carroll; Bercin K Cenik; Beibei Chen; Ning Liu; Eric N Olson; Rhonda Bassel-Duby
Journal:  Dev Biol       Date:  2015-09-16       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.